[1] |
MANGALAM A K,TANEJA V,DAVID C S.HLA class Ⅱ molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile[J].J Immunol,2013,190(2):513-518.
|
[2] |
IBISCH C,SAULQUIN X,GALLOT G,et al.The T cell repertoire selected in vitro against EBV: diversity,specificity,and improved purification through early IL-2 receptor alpha-chain(CD25)-positive selection[J].J Immunol,2000,164(9):4924-4932.
|
[3] |
苏犁云,徐锦,孙家娥,等. EB病毒感染实验室诊断方法探讨[J]. 检验医学,2006,21(5):513-516.
|
[4] |
龙彦,刘畅,孙媛媛,等. EB病毒急性感染的实验室血清学诊断方法研究[J]. 中国全科医学,2015,18(5):582-584.
|
[5] |
ICHEVA V,KAYSER S,WOLFF D,et al.Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation[J]. J Clin Oncol,2013,31(1):39-48.
|
[6] |
WILSDORF N,EIZ-VESPER B,HENKE-GENDO C,et al.EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease[J]. Transplantation,2013,95(1):247-255.
|
[7] |
CHEN D B,WANG Y,SONG Q J,et al.Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases[J]. Zhonghua Bing Li Xue Za Zhi,2012,41(9):607-612.
|
[8] |
PANIZ-MONDOLFI P, PANG Y,COHEN S, et al.Lymphoepithelioma-like gastric carcinoma: an unusual consequence of Epstein-Barr virus infection in an HIV-infected woman[J]. Int J STD AIDS,2013,24(1):59-62.
|
[9] |
KLEIN E,KIS L L,KLEIN G.Epstein-Barr virus infection in humans:from harmless to life endangering virus-lymphocyte interactions[J]. Oncogene,2007,26(9):1297-1305.
|
[10] |
MACARTHUR G J,WILSON A D,BIRCHALL M A,et al.Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells[J]. J Virol,2007,81(9):4766-4775.
|
[11] |
王新云. BAFF,IL17在系统性红斑狼疮中的表达以及与EB病毒感染的关系[D]. 青岛:青岛大学,2014.
|
[12] |
付强,周艳玲,宋晓翔,等. 共刺激分子CD40/CD40L在儿童慢性活动性EB病毒感染中的作用[J]. 实用儿科临床杂志,2011,26(22):1716-1718.
|